prostate cancer Archives - Page 61 of 64 - Sperling Prostate Center

Multiparametric MRI Minimizes Biopsy Needles, Maximizes Accuracy

I recently posted a summary of an Italian study showing that MRI (mpMRI) was superior to other prostate cancer tests in terms of predicting the need for a repeat biopsy after a previously negative result. mpMRI is able to show if there is a need for another biopsy. This is happy news for patients, who dread having keep reading

Too Fat for Active Surveillance?

I have written on the importance of a healthy lifestyle, especially diet and nutrition, which is correlated with preventing prostate cancer (PCa) and other diseases. (NOTE: You can read some of my related blogs from links at the end of this one.) I came across a new multi-center Italian study that addresses the question: does keep reading

Post-prostatectomy Rates of ED Have Not Improved

Erectile Function and Prostate Cancer - Sperling Prostate Center

I remember being at a medical convention about 10 years ago and overhearing a conversation between two doctors, specialty unknown, who were speaking positively about Dr. Patrick Walsh’s famous contribution, the nerve-sparing radical prostatectomy (RP). As I later learned, he first applied his technique in 1982, and the patient regained potency about a year after keep reading

Medical Change at the Grassroots Level: A New Year’s Wish

“Power to the people!” This slogan, and variations of it, took on a life of its own in the Sixties and Seventies. John Lennon even wrote a song with that title, and James Brown used it as a lyric. Change that comes as a result of a social movement is often referred to as change keep reading

Call to Action: Make Your Voice Heard

I can’t begin to count the number of times patients have asked me questions like these: “Why isn’t focal laser ablation covered by Medicare or insurance?” “My urologist said he won’t do my follow-up if I have focal laser ablation. Do you know a laser-friendly urologist in my area who will work with me?” “How keep reading

The PSA Screening Debate

On November 18, 2015 the New York Times carried an article titled “Early Prostate Cancer Cases Fall Along With Screening.” Ever since the U.S. Preventive Services Task Force recommended against broad PSA screening on the grounds that it leads to overdetection and overtreatment, two opposing positions have been created. One position favors the recommendation on keep reading

A Brief Imaging Update

Roughly 14% of American men will be diagnosed with prostate cancer (PCa) in their lifetime. It is the second leading cause of death in men, after lung cancer—yet it is a highly curable disease if caught early, and if choice of treatment matches the disease. This year, over 220,000 new cases will be diagnosed. Today, keep reading

Heart-Healthy Choices Promote Prostate Health

Mark Moyad, MD, professor of preventive and alternative medicine at the University of Michigan, is renowned for his extensive knowledge on how nutrition, supplements and exercise protect against prostate cancer. He recently published a detailed report, “Preventing Aggressive Prostate Cancer with Proven Cardiovascular Disease Preventive Methods.”[i] He lists risk factors for cardiovascular disease (CVD) that keep reading

Let’s Talk About Informed Decision Making

How do you prepare for a prostate cancer consultation? While I can’t speak for everyone in my profession, I believe these days most urologists and radiologists are comfortable with patients bringing in a list of questions. I encourage patients to do so, especially if they are facing a detection, diagnosis, or decision-making process regarding prostate keep reading

Testosterone Replacement Delivery Systems

Thanks to new evidence that testosterone replacement therapy (TRT) does not increase prostate cancer risk, many PCa patients with low testosterone are breathing sighs of relief. Testosterone levels tend to decrease as men age, by about 1% per year after age 30. Low testosterone – also called low T or hypogonadism – affects approximately 13 keep reading

Tag: prostate cancer